Algert Global’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-72,026
Closed -$301K 1263
2026
Q1
$301K Buy
72,026
+30,850
+75% +$148K ﹤0.01% 1020
2025
Q4
$198K Sell
41,176
-15,958
-28% -$77.2K ﹤0.01% 1063
2025
Q3
$289K Sell
57,134
-13,330
-19% -$58.9K ﹤0.01% 1004
2025
Q2
$284K Buy
70,464
+9,040
+15% +$29.4K 0.01% 1034
2025
Q1
$168K Sell
61,424
-6,820
-10% -$24.5K ﹤0.01% 1100
2024
Q4
$290K Buy
68,244
+35,120
+106% +$134K 0.01% 997
2024
Q3
$97.4K Buy
33,124
+6,070
+22% +$19.3K ﹤0.01% 1113
2024
Q2
$94.1K Sell
27,054
-7,784
-22% -$26K ﹤0.01% 1395
2024
Q1
$99.3K Buy
+34,838
New +$107K ﹤0.01% 1013

Other funds holding SRTA

Algert Global's SRTA Position: Q2 2026 in Review

Algert Global sold out of Strata Critical Medical Inc (SRTA) in Q2 2026, closing a stake of 72,026 shares — an estimated $301K sold.

Algert Global first reported a position in SRTA in Q1 2024 and held it in 9 quarters. The position peaked at $301K in Q1 2026. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Algert Global reported no remaining Strata Critical Medical Inc position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 72,026 Strata Critical Medical Inc shares in Q2 2026, an estimated $301K.
  • Algert Global first reported a position in Strata Critical Medical Inc in Q1 2024 and held it in 9 quarters.
  • Algert Global's Strata Critical Medical Inc position peaked at $301K in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.